MIM
AMPH icon

Monashee Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Monashee Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,461
Closed -$1.81M – 48
2023
Q3 		$1.81M Buy
+39,461
New +$2.15M 0.76% 44

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Monashee Investment Management's AMPH Position: Q4 2023 in Review

Monashee Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 39,461 shares — an estimated $1.81M sold.

Monashee Investment Management first reported a position in AMPH in Q3 2023 and held it in 1 quarter. The position peaked at $1.81M in Q3 2023. 276 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • Monashee Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Monashee Investment Management sold 39,461 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $1.81M.
  • Monashee Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Monashee Investment Management's Amphastar Pharmaceuticals position peaked at $1.81M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on Monashee Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.